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Background
The sequence of adenoma-cancer has been broadly docu-
mented, being accepted as the aberrant crypt-adenoma-
cancer concept. These lesions are detected early in colonic
carcinogenesis, but only a minority presents dysplasia.
The objectives of the study are:1) to identify and measure
FAC in patients with different levels of risk to develop
colorectal cancer;2) to correlate FAC with magnification
endoscopy and histopathological study, and 3) to corre-
late FAC histopathologically confirmed with over-expres-
sion of Ki-67 and p53.
Materials and methods
We made a cases-controlled study at the endoscopy serv-
ice of the Instituto Nacional de Cancerologia-Mexico from
March to June 2006. We selected patients with different
indications for colonoscopy according to the potential
risk for colorectal cancer. We made chromoendoscopy
with magnification in the last 10 cm of the rectum and we
took biopsies on the FAC sites; the samples were analyzed
for a blind-test pathologist and we realized immunohisto-
chemistry for p53 and Ki-67.
Results
We selected 24 patients, 10 male, 14 female, which were
separated in groups according to the risk:
Group 1: n = 8, mean age 52.3 years-old, ED 15.61. The
most common indications for colonoscopy were chronic
diarrhea, anemic syndrome digestive tract bleeding. The
mean FAC were 2.5(0–8), in all cases corresponding to
Kudo's types IIIL and IIIs.
Group 2: n = 16, mean age 45.3 y-o, SD 16.91. Of them 7/
16 had CRC at the moment of the study, 7/16 just oper-
ated for CRC and 2/16 with familiar adenomatous poly-
posis (FAP). The mean FAC were 6.25(0–22) that shows a
statistical difference p < 0.001 with the mild risk group. In
all cases corresponded to Kudo's patterns IIIL and IIIs. The
sensitivity and specificity of chromoscopy with magnifica-
tion to detect FAC were 83% and 56%, respectivly (p =<
0.00021), predictive positive value 31, predictive negative
value 98. The observed concordance for presence or
absence of FAC was 64%. The frequency of FCA-D for
group 1 was 1.35%, group 2 18% (p < 0.00021). With
respect to sporadic CRC and FAP-related CRC were 11.7%
and 6.3%. The high risk patients with FAC had an odds-
ratio (OR) 4.91, CI 95% (2.53, 9.74) (p =< 0.000000016).
On group 2 with FCA-D the OR 8.58, CI 95% {2.82, 36.2}
(p =< 0.000051). The over-expression of p53 was detected
in only 6% of patients with FAC-D and high risk (p =
0.58).
Ki-67 was positive in 100% of FAC-D, FAC-H and FAC
NH-ND).
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Conclusion
The frequency and intensity of FAC are higher in high risk
population for CRC. The presences of FAC-D increase the
risk 8-times more than in medium population. Chromo-
scopy with magnification has a low specificity and high
sensitivity to detect FAC. The Ki-67 over-expression in
FAC is present in almost all the cases, disregard to p53
which is over-expressed in a minority of FAC-D, which
means deorganized hyperproliferation and that probably
p53 is not present on FAC of sporadic CRC patients.